학술논문
Safety, tolerability, and pharmacokinetics of half-life extended SARS-CoV-2–neutralizing monoclonal antibodies AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults
Document Type
Article
Author
Source
In Journal of Infection and Chemotherapy November 2023 29(11):1061-1067
Subject
Language
ISSN
1341-321X